Predict your next investment

Verilux company logo
HEALTHCARE | Medical Devices & Equipment / Therapeutic Devices
toolsforwellness.com

See what CB Insights has to offer

About Verilux

Verilux is a medical device company. It had developed the Clearwave Phototherapy System For Acne, Model: Cwst2.Find White Noise Machines, Marpac Sound Screens, Sleep Aids, BioFeedback Machines, Verilux lighting, Meditation CDs & Alternative Health & Therapy products with Free Shipping at Tools for Wellness

Verilux Headquarter Location

391 Bridge Point Dr.

South Saint Paul, Minnesota, 55075,

United States

Latest Verilux News

Seasonal Affective Disorder Therapeutics Market 2028 Size, Industry Share, Growth, Trends and Top Key Players: Verilux, Inc., Carex Health, Northern Light Technologies, Beurer GmbH, and Koninklijke Philips N.V.

May 13, 2021

Seasonal Affective Disorder Therapeutics Market 2028 Size... Search jobs 13-May-2021 Seasonal Affective Disorder Therapeutics Market 2028 Size, Industry Share, Growth, Trends and Top Key Players: Verilux, Inc., Carex Health, Northern Light Technologies, Beurer GmbH, and Koninklijke Philips N.V. A recent market study published by FMI– “Seasonal Affective Disorder Therapeutics Market: Global Industry Analysis 2013-2017 & Opportunity Assessment 2018-2028” consists of a comprehensive assessment of the most important market dynamics. On conducting a thorough research of the historic as well as current growth parameters of the Seasonal Affective Disorder Therapeutics market, the growth prospects are obtained with maximum precision. The Seasonal Affective Disorder Therapeutics market report features the unique and salient factors that are likely to significantly impact the development of the Seasonal Affective Disorder Therapeutics market during the forecast period. It can help market players to modify their manufacturing and marketing strategies to envisage maximum growth in the Seasonal Affective Disorder Therapeutics market in the upcoming years. The report provides detailed information about the current and future growth prospects of the Seasonal Affective Disorder Therapeutics market in the most comprehensive manner for the better understanding of readers. Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-8821 Chapter 1 – Executive Summary The Seasonal Affective Disorder Therapeutics market report commences with an executive summary of the key findings and key statistics of the Seasonal Affective Disorder Therapeutics market. It also includes the market value (US$ million) estimates of the leading segments of the Seasonal Affective Disorder Therapeutics market. Chapter 2 – Market Overview Readers can find detailed taxonomy and the definition of the Seasonal Affective Disorder Therapeutics market in this chapter, which helps understand the basic information about the Seasonal Affective Disorder Therapeutics. This section also highlights the inclusions and exclusions, which helps the reader understand the scope of the Seasonal Affective Disorder Therapeutics market report. Chapter 3 – Market Background This chapter explains the key macro-economic factors that are expected to influence the growth of the Seasonal Affective Disorder Therapeutics market over the forecast period. Along with macroeconomic factors, this section also highlights the opportunity analysis for the Seasonal Affective Disorder Therapeutics market. This chapter also highlights the key dynamics of the Seasonal Affective Disorder Therapeutics market, which include the drivers, restraints and trends. Moreover, readers will understand the key trends followed by the leading manufacturers in the Seasonal Affective Disorder Therapeutics market. Chapter 4 – Key Success Factors This chapter highlights the key success factors of the Seasonal Affective Disorder Therapeutics market report, which include key regulations, disease epidemiology and comprehensive list of FDA approved light therapy devices. The key regulations section of this chapter highlights the FDA and EMA regulatory processes for the approval of drugs and devices. Disease epidemiology highlights the prevalence rate and treatment seeking rate of seasonal affective disorder. Chapter 5 – Global Seasonal Affective Disorder Therapeutics Market Volume Analysis 2013-2017 & Opportunity Assessment 2018-2028 This section explain the global market volume analysis and forecast for the Seasonal Affective Disorder Therapeutics market. The sale of different types of devices for Seasonal Affective Disorder Therapeutics for every year between the forecast periods of 2013-2028 is highlights in this section. Chapter 6 – Global Seasonal Affective Disorder Therapeutics Market: Pricing Analysis This section highlights the average price of light boxes, dawn stimulator, desk lamps and sun visor in the different region throughout the globe. The pricing benchmark for manufacturer level pricing and distributor level pricing is analysed in this section. Chapter 7 – Global Seasonal Affective Disorder Therapeutics Market Value Analysis 2013-2017 & Opportunity Assessment 2018-2028 This section explain the global market analysis and forecast for the Seasonal Affective Disorder Therapeutics market. It also highlights the incremental opportunity for the Seasonal Affective Disorder Therapeutics market along with the absolute dollar opportunity for every year between the forecast period of 2018-2028. Chapter 8 – Global Seasonal Affective Disorder Therapeutics Market Analysis 2013-2017 & Opportunity Assessment 2018-2028, By Treatment Type Based on the treatment type, the Seasonal Affective Disorder Therapeutics market Drugs and devices. In this chapter, readers can find a detailed analysis of the Seasonal Affective Disorder Therapeutics market by different treatment types and their expected growth over the forecast period. Chapter 9 – Global Seasonal Affective Disorder Therapeutics Market Analysis 2013-2017 & Opportunity Assessment 2018-2028, By Disorder Type Based on the Disorder Type, the Seasonal Affective Disorder Therapeutics market is segmented as unipolar disorder and bipolar disorder. This section helps readers understand the penetration of both disorder type in the Seasonal Affective Disorder Therapeutics market over the forecast period. Chapter 10 – Global Seasonal Affective Disorder Therapeutics Market Analysis 2013-2017 & Opportunity Assessment 2018-2028, By Distribution Channel Based on the distribution channel, the Seasonal Affective Disorder Therapeutics market is segmented into retail sales and institutional sales. In this chapter, readers can understand the market attractive analysis based on the distribution channel. Chapter 11 – Global Seasonal Affective Disorder Therapeutics Market Analysis 2013-2017 & Opportunity Assessment 2018-2028, By Region This chapter explains how the Seasonal Affective Disorder Therapeutics market will grow across various geographic regions such as North America, Latin America, Europe, East Asia, South Asia, Oceania and the Middle East & Africa (MEA). Chapter 12 – North America Seasonal Affective Disorder Therapeutics Market Analysis 2013-2017 & Opportunity Assessment 2018-2028 This chapter includes a detailed analysis of the growth of the North America Seasonal Affective Disorder Therapeutics market along with a country-wise assessment, which includes the U.S. and Canada. Readers can also find the key takeaways of this region, and market growth based on treatment type, disorder type, distribution channel and country of Seasonal Affective Disorder Therapeutics in the North America region. Chapter 13 – Latin America Seasonal Affective Disorder Therapeutics Market Analysis 2013-2017 & Opportunity Assessment 2018-2028 This chapter contains a snapshot of the Latin America Seasonal Affective Disorder Therapeutics market. It includes the growth prospects of the Seasonal Affective Disorder Therapeutics market in the leading LATAM countries such as Brazil, Mexico, Argentina and the rest of the Latin America region. Chapter 14 – Europe Seasonal Affective Disorder Therapeutics Market Analysis 2013-2017 & Opportunity Assessment 2018-2028 The important growth prospects of the Seasonal Affective Disorder Therapeutics market based on its radionuclide type, indication and distribution channel in several European countries, such as the U.K., Germany, France, Italy Spain, Russia and the rest of Western Europe, is included in this chapter. Chapter 15 – East Asia Seasonal Affective Disorder Therapeutics Market Analysis 2013-2017 & Opportunity Assessment 2018-2028 This chapter highlights the growth of the Seasonal Affective Disorder Therapeutics market in Eastern Europe by focusing on China, Japan and South Korea. This section also helps readers understand the key factors that are responsible for the growth of the Seasonal Affective Disorder Therapeutics market in East Asia. Chapter 16 – South Asia Seasonal Affective Disorder Therapeutics Market Analysis 2013-2017 & Opportunity Assessment 2018-2028 India, Indonesia, Thailand , Malaysia are the leading countries in the South Asia region that are the prime subjects of assessment to obtain the growth prospects of the South Asia Seasonal Affective Disorder Therapeutics market in this chapter. Readers can find detailed information about the growth parameters of the South Asia Seasonal Affective Disorder Therapeutics market during the period 2018-2028. Chapter 17 – Oceania Seasonal Affective Disorder Therapeutics Market Analysis 2013-2017 & Opportunity Assessment 2018-2028 Readers can find important factors that can significantly impact the growth of the Seasonal Affective Disorder Therapeutics market in Australia and New Zealand during the forecast period based on the market segmentation. Chapter 18 – MEA Seasonal Affective Disorder Therapeutics Market Analysis 2013-2017 & Opportunity Assessment 2018-2028 This chapter provides information about the growth of the Seasonal Affective Disorder Therapeutics market in the major countries of the MEA region, such as GCC Countries and South Africa, during the period 2018-2028. Request for Report Ask A Question @ https://www.futuremarketinsights.com/ask-question/rep-gb-8821 Chapter 19 – Competition Landscape In this chapter, readers can find a comprehensive list of all the leading manufacturers in the Seasonal Affective Disorder Therapeutics market, along with detailed information about each company, which includes the company overview, revenue shares, strategic overview, recent company developments. Some of the players featured in the Seasonal Affective Disorder Therapeutics market report are Allergan plc., Eli Lily Company, GlaxoSmithKline plc,  Pfizer Inc., Teva Pharmaceuticals Inc., Bausch Health Companies Inc., F. Hoffmann-La Roche AG, Mylan N.V., Sanofi AG, Novartis AG, Janssen Pharmaceuticals, Inc., The Sunbox Company,  Verilux, Inc., Carex Health, Northern Light Technologies, Beurer GmbH, and Koninklijke Philips N.V. Chapter 20 – Assumptions and Acronyms This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the report. Chapter 21 – Research Methodology This chapter helps readers understand the research methodology followed to obtain various conclusions and important qualitative information & quantitative information about the Seasonal Affective Disorder Therapeutics market. Explore Wide-ranging Coverage of FMI’s HealthcareLandscape Mammalian Transient Protein Expression Market  –The mammalian transient protein expression market has reflected steady growthon the back of growing demand from the biomedicine sector. Efforts into vaccinedevelopment continue to create possibilities for new opportunities. In Vitro Fertilization Banking Services Market  –According to the Centers for Disease Control and Prevention (CDC), about 10% ofwomen in the United States between ages 15 to 44 years have infertility whilethe rate of male infertility is 4.5-6% in North America. Cryopreservation for In-vitro Fertilization (IVF) Market  –According to analysis by Future Market Insights (FMI), cryopreservationfor IVF market surpassed a valuation of US$ 339 million in 2019. Themarket is set to reflect an impressive 10.2% CAGR through 2030. About FMI        Future Market Insights (FMI) is a leading provider of marketintelligence and consulting services, serving clients in over 150 countries. FMI  isheadquartered in Dubai, the global financial capital, and has delivery centersin the U.S. and India. FMI’s latest  marketresearch reports  and industry analysis help businesses navigatechallenges and make critical decisions with confidence and clarity amidstbreakneck competition. Our customized and syndicated market research reportsdeliver actionable insights that drive sustainable growth. A team of expert-ledanalysts at FMI continuously tracks emerging trends and events in a broad rangeof industries to ensure that our clients prepare for the evolving needs oftheir consumers. ContactUs

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Verilux

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Verilux is included in 1 Expert Collection, including Sleep Health & Wellness.

S

Sleep Health & Wellness

795 items

These companies aim to assess or improve the quantity/quality of sleep, or use sleep data in the monitoring or diagnosis of other health conditions.

Verilux Patents

Verilux has filed 20 patents.

The 3 most popular patent topics include:

  • Circadian rhythm
  • Culture
  • Cuttlefish
patents chart

Application Date

Grant Date

Title

Related Topics

Status

10/24/2018

8/11/2020

Technical drawing, Graphical projections, Cuttlefish, Honeycombs (geometry), Goldfish breeds

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

10/24/2018

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

8/11/2020

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Technical drawing, Graphical projections, Cuttlefish, Honeycombs (geometry), Goldfish breeds

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Verilux Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Verilux Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.